Abstract:
Certain hexane and heptane amines including geometric and stereoisomers, agricultural compositions containing them and their use as fungicides.

Description:
BACKGROUND OF THE INVENTION 
     EP0259977 claims fungicidal compounds of the formula ##STR1## wherein: R 1 , R 2  and R 3  are independently H, halogen or C 1  -C 4  alkyl; 
     R 4  is H or C 1  -C 4  alkyl; 
     R 5  and R 6  are C 1  -C 4  alkyl or R 5  and R 6  together with the adjacent nitrogen atom form a heterocyclic ring which may contain an additional heteroatom; 
     X and Y are H, halogen, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, aryl, aralkyl, alkoxy, aryloxy or a substituted Si; and 
     Q and Z are optionally-substituted alkyl groups not containing any fused three-membered rings. 
     EP 278311-A claims fungicidal compounds of the general formula ##STR2## wherein: R 1  is optionally substituted aryl, heteroaryl, cycloalkyl, tetrahydronaphthyl or decahydronaphthyl; 
     R 2  is H or CH 3  ; and 
     R 3  and R 4  are H, alkyl, alkenyl, alkynyl, alkoxyalkyl, dialkoxyalkyl, hydroxyalkyl, hydroxyalkoxyalkyl, dioxolanylalkyl, oxolanylalkyl, dioxanylalkyl or optionally substituted cycloalkylalkyl, cycloalkyl, aralkyl, aralkenyl or aryl, or NR 3  R 4  is an optionally substituted saturated ring optionally containing other heteroatoms. 
     GB 2,216,120 discloses fungicidal compounds of the formula ##STR3## wherein: R 1  -R 8  are H or (halo)alkyl; 
     R 9  and R 10  are (halo)alkyl; 
     NR 9  R 10  is heterocyclyl; and 
     X is H, halogen, (halo)alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl, alkoxy, aryloxy or silyl. 
     None of these publications disclose the compounds of the instant application. 
     SUMMARY OF THE INVENTION 
     This invention pertains to compounds of the Formula I including all geometrical isomers but restricted to the stereoisomers in which R 1  and NR 5  R 6  are trans- to one another, agricultural compositions containing them and their use as fungicides. ##STR4## wherein: n is 1 or 2; 
     m is 0 or 1; 
     p is 0 or 1; 
     Q is C, O or S; 
     Y is O or CR 6  R 7  ; 
     R 1  is C 4  -C 10  alkyl, C 4  -C 10  alkenyl, C 4  -C 10  alkynyl, C 4  -C 10  cyanoalkyl, C 3  -C 10  cycloalkyl optionally substituted with C 1  -C 6  alkyl, 2-thienyl substituted with R 8  and R 9 , or R 1  is phenyl substituted with R 8  and R 9 , or R 1  is styryl substituted with R 8  and R 9 , or R 1  is ##STR5## R 2 , R 3 , R 10 , and R 11  are independently H, CN, halogen, C 1  -C 4  alkyl, C 1  -C 4  alkoxy or C 1  -C 4  haloalkyl; 
     R 4  and R 5  are independently C 1  -C 6  alkyl, phenethyl optionally substituted with 1-3 substituents selected from the group consisting of halogen, CN and C 1  -C 4  alkyl, or R 4  and R 5  may be taken together with the nitrogen to which they are attached to form heterocycles of the formulas: ##STR6## R 6  and R 7  are independently H, halogen, methyl, methoxy, CN or trifluoromethyl; 
     R 8  and R 9  are independently H, halogen, CN, C 1  -C 6  alkyl, C 1  -C 6  cyanoalkyl, C 1  -C 6  haloalkyl, C 3  -C 6  cycloalkyl, C 3  -C 6  cycloalkylmethyl, C 2  -C 6  alkenyl, C 2  -C 6  alkynyl, C 1  -C 6  alkoxy, phenyl optionally substituted with halogen, CN or C 1  -C 4  alkyl, phenoxy optionally substituted with halogen, CN or C 1  -C 4  alkyl, or silicon substituted with any three of the group consisting of C 1  -C 4  alkyl, C 2  -C 4  alkenyl, C 2  -C 4  alkynyl and C 1  -C 3  haloalkyl; 
     R 12  and R 13  are independently H, halogen, CN, C 1  -C 4  alkyl, C 2  -C 4  alkenyl, C 1  -C 4  alkoxy, C 1  -C 4  hydroxyalkyl or phenyl optionally substituted with 1-2 halogen; 
     R 14  and R 15  are independently H, halogen, CN, C 1  -C 4  alkyl or C 1  -C 4  alkoxy; 
     R 16  is H, OH, halogen, CN, C 1  -C 4  alkyl or C 1  -C 4  alkoxy; 
     X is O or NR 17  ; 
     R 17  is H, OH, C 1  -C 3  alkyl or C 1  -C 3  alkoxy; 
     Z is O or CH 2  ; 
     and the agriculturally suitable salts thereof provided that: 
     1) When m is 1, n is 1; 
     2) When m is 0 and Q is O or S, Y is CR 6  R 7  ; 
     3) When R 4  and R 5  are taken together to form heterocycles of the Formula A-5, R 12  and R 13  may be substituted at positions 2, 3, 8, 9 or 10 and R 14 , R 15  and R 16  may be substituted at positions 4, 5, 6 or 7; 
     4) When R 2  or R 3  are halogen or C 1  -C 4  alkoxy, then they must not be substituted on a carbon atom attached to O, S or N; 
     5) When R 2  or R 3  is CN, then they must not be substituted at the carbon atom attached to NR 4  R 5 . 
     Preferred for ease of synthesis and/or fungicidal activity are: 
     1) A compound of Preferred 1 of the formula: ##STR7## 2) A compound of Preferred 1, wherein: Y is O or CH 2  ; 
     R 2  is H, CH 3 , CH 2  CH 3  or CN; 
     R 4  and R 5  are taken together to form heterocycles of the formula A-1, A-2, A-3, A-4 or A-5; 
     R 8  and R 9  are independently H, halogen, CN, C 1  -C 6  alkyl, C 1  -C 6  cyanoalkyl, C 1  -C 6  haloalkyl or C 3  -C 6  cycloalkyl; 
     R 12  and R 13  are independently H, CN, C 1  -C 4  alkyl, C 1  -C 4  alkoxy or C 1  -C 4  hydroxyalkyl; 
     R 14  and R 15  are independently H, CN or CH 3  ; 
     R 16  is H or OH; and 
     X is O. 
     3) A compound of Preferred 2 wherein: 
     m is 0; 
     n is 1; and 
     Q is CH 2 . 
     4) A compound of Preferred 3 wherein: 
     R 4  and R 5  are taken together to form heterocycles of the structures A-1, A-3 or A-4. 
     5) A compound of Preferred 4 wherein: 
     R 1  is C 4  -C 10  alkyl, C 4  -C 10  cycloalkyl optionally substituted with C 1  -C 6  alkyl, or R 1  is phenyl substituted with R 8 , or R 1  is benzyl substituted with R 8  on the aryl moiety; 
     R 2  is H, CH 3  or CN; 
     R 8  is H, C 1  -C 6  alkyl, C 3  -C 4  cycloalkyl, CN or CF 3  ; and 
     R 13  and R 14  are independently H or CH 3 . 
     6) Specifically preferred is 
     1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-dimethyl-piperidine, [1α,2β,5α]. 
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     Synthesis 
     Compounds of Formula I in which p is 1 can be prepared from compounds of Formula I in which p is 0 by oxidation with an appropriate reagent for the conversion of amines to amine-N-oxides. Appropriate reagents include peroxides such as hydrogen peroxide or t-butylhydroperoxide, peracids such as 3-chloroperbenzoic acid or peracetic acid, or Oxone® (2KHSO 5 .KHSO 4 .K 2  SO 4 ). The reaction may be catalyzed with group V or group VI metals [see Shong and Fujuret, J. Org. Chem. 33, 588 (1968)]. 
     Compounds of Formula I in which p=0 can be prepared by the displacement of a leaving group LG in II with an amine III. Typical values for LG include halides and sulfonates. The reaction is run neat with one to three equivalents of the amine with or without an additional base such as potassium carbonate at temperatures between 25° C. and 150° C. In addition, a solvent such as DMF, tetrahydrofuran or ethanol may be used. ##STR8## 
     Compounds of Formula Ia wherein NR 4  R 5  form the heterocycle of Formula A-1 can also be prepared from the corresponding quaternary pyridinium salt of Formulas IVa (where W- is an organic or inorganic counterion such as a sulfonate or halide) by hydrogenation over an appropriate transition metal catalyst (TMC) such as palladium, platinum or rhodium. Typically, the catalyst is deposited over an inert support such as carbon, alumina or calcium carbonate. The hydrogenations are carried out in protic solvents such as ethanol or non-protic solvents such as tetrahydrofuran or ethyl acetate. Pressures of 1-10 atm of hydrogen are required. The hydrogenations are typically run at 25° C. but may be run at temperatures up to 100° C. Optionally, 1-2  equivalents of a base such as potassium carbonate or triethylamine may be added to neutralize the acid produced by the hydrogenation. The salts of Formula IVa can be prepared by displacement of LG in II with a pyridine V. The reaction is run neat with 1 to 100 equivalents of V at temperatures between 25° C. and 100° C. In addition, a solvent such as DMF, dichloroethane or ethanol may be used. ##STR9## 
     Compounds of Formula Ib where NR 4  R 5  form the heterocycle of A-2 can be prepared from IVa by reduction with a hydride reagent such as sodium borohydride, sodium cyanoborohydride, tetrabutylammonium cyanoborohydride, or sodium formate. The reductions are run at -20° C. to 100° C. in protic solvents such as ethanol or aprotic solvents such as DMF, tetrahydrofuran or methylene chloride. ##STR10## 
     Alternatively, compounds of Formula I can be prepared by reductive amination of compounds of Formula V with amine III. The reactions are run with 1-10 equivalents of the amine and with a reducing reagent such as formic acid, sodium cyanoborohydride or tetrabutylammonium cyanoborohydride. Addition of a protic acid such as HCl or p-toluenesulfonic acid is often useful to catalyze the reductive amination. Reaction temperatures can vary from 0° C. to 100° C. Appropriate solvents include alcohols such as methanol or ethanol, or aprotic solvents such as dimethylformamide or methylene chloride. ##STR11## 
     The compounds IIa in which ##STR12## is a sulfonate can be prepared from an alcohol VI and a sulfonyl chloride (e.g., toluenesulfonyl chloride) or a sulfonic anhydride (e.g., trifluoromethane sulfonic anhydride) and a base such as pyridine or triethylamine in a solvent such as pyridine, methylene chloride or tetrahydrofuran at temperatures between 0° C. and 25° C. Compounds IIb in which Hal is a halogen can be prepared from VI using standard conditions known to one familiar in the art such as treatment with thionyl chloride or phosphorus tribromide. The iodide can be prepared from the chloride or bromide using sodium iodide in acetone or methyl ethyl ketone. ##STR13## 
     Those skilled in the art will recognize that alcohol VI is interconvertable with compound V if R 2  and R 3  are not positioned on the alcohol bearing carbon. Alcohols VI can be oxidized to V by methods set out in the literature (see leading references in J. March, Advanced Organic Chemistry, 3rd Ed., J. Wiley and Sons, New York, N.Y., 1985, pp. 1057-1060). Typical oxidizing reagents include pyridinium dichromate, chromium trioxide in pyridine, and dimethyl sulfoxide/oxalyl chloride (Swern oxidation). Compound V may in turn be reduced to VI by a number of methods set out in the literature (see J. March, Advanced Organic Chemistry, 3rd Ed., J. Wiley and Sons, New York, N.Y., 1985, pp. 809-814). Typical reducing reagents are sodium borohydride or lithium aluminum hydride. Thus, compounds V or VI can serve as intermediates in the synthesis of compounds of this invention. ##STR14## 
     Compounds V and VI can be synthesized from VII and VIII respectively by standard methods of epoxidation (i.e., with perbenzoic acids, peracetic acids, basic hydrogen peroxide, basic t-butylperoxide, or aqueous N-bromosuccinimide followed by base) for Y=O and by standard methods of cyclopropanation (i.e., Simmons-Smith reaction, diazo insertion reaction, carbene insertion reaction, sulfur ylide transfer reagents; see J. March, Advanced Organic Chemistry, 3rd Ed., J. Wiley and Sons, New York, N.Y., 1985, pp. 768-774) for Y=CR 6  R 7 . ##STR15## 
     Alcohol VIII may be oxidized to VII and VII may be reduced to VIII as described previously for the interconversions of V and VI (vide supra). ##STR16## 
     Compounds of Formulas VI and VIII in which the hydroxyl is positioned on a tertiary carbon may be synthesized by addition of an organometallic reagent R 2  M or R 3  M (when R 2  and R 3  are C 1  -C 4  alkyl or C 1  -C 4  haloalkyl and in which M is typically lithium or a magnesium halide) to ketones V and VII, respectively. 
     Compounds of Formula VII are available by a number of methods set out in the literature. For example, compounds of Formula VII can be prepared by reaction of compounds of Formula IX with an organometallic reagent R 1  M in an ethereal solvent such as tetrahydrofuran or diethyl ether. Compounds of Formula IX are generally known in the literature. ##STR17## 
     Alternatively, compounds of Formula VII may be prepared by reaction of compounds of Formula X with an organometallic reagent R 1  M in an ethereal solvent such as tetrahydrofuran or diethyl ether to form XI. Oxidation of XI with an oxidant such as CrO 3  /H 2  SO 4  in an ethereal solvent affords VII. Compounds of Formula X are generally known in the literature. ##STR18## 
     Those skilled in the art will recognize that Formula I compounds can contain two or more asymmetric carbon atoms. The stereoisomers that result can be separated using standard methods known in the art if desired. 
     EXAMPLES 
     Example 1 
     Synthesis of 1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-dimethylpiperidine-[1α,2β,5α] 
     A solution of 25.7 g (0.12 mol) of 3-(4-t-butylphenyl)-2-methyl-2-cyclopenten-1-one (EP 0259977) dissolved in 40 mL of ether was cooled to 0° C. Added dropwise was 43.7 mL (43.7 mmol) of a solution of 1M lithium aluminum hydride in THF. After stirring 20 min, the mixture was quenched by dropwise addition of saturated aqueous NaHSO 3 . The mixture was dried (MgSO 4 ), solids were filtered and the filtrate was stripped to afford 26.8 g of 1-(4-t-butylphenyl)-2-methyl-cyclopenten-3-ol as an oil which slowly solidified. 
     A solution of 23.6 g (0.10 mol) of 1-(4-t-butylphenyl)-2-methyl-cyclopenten-3-ol was dissolved in 20 mL of CH 2  Cl 2  and cooled in an ice-water bath. Saturated aqueous Na 2  CO 3  (50 mL) was added. 19.4 g (0.11 mol) of 80% m-chloroperbenzoic acid was added and the mixture was stirred 30 min. 50 mL of saturated aqueous NaHSO 3  was added as was 100 mL more saturated aqueous Na 2  CO 3 . The mixture was extracted twice with CH 2  Cl 2  which was in turn washed with water and brine. Drying (MgSO 4 ) and removal of solvent afforded 24.5 g of 5-(4-t-butyl-phenyl)-1-methyl-6-oxabicyclo[3.1.0]hexan-2-ol[1α,2.beta.,5α] as an oil which slowly solidified. 
     A solution of 23.8 g of 5-[4-t-butylphenyl)-1-methyl-6-oxabicyclo[3.1.0]hexan-2-ol[1α,2.beta.,5α] in 100 mL CH 2  Cl 2  was added dropwise to a suspension of 54.6 (0.145 mol) pyridinium dichromate and 7.5 g (39 mmol) of pyridinium trifluoroacetate in 150 mL CH 2  Cl 2  at room temperature. The mixture was stirred two days before being poured into 1 L of ether. The ether solution was filtered through a silica gel pad which was subsequently washed with additional ether. The filtrate was stripped and the residue was chromatographed on silica gel with 9:1 hexanes/ether to afford 13.8 g of 5-(4-t-butylphenyl)-1-methyl-6-oxabicyclo[3.1.0]hexan-2-one as an oil that slowly solidified. 
     A solution of 2.66 g (10.8 mmol) of 5-(4-t-butylphenyl)-1-methyl-6-oxabicyclo[3.1.0]hexan-2-one, 5.0 g (44 mmol) of cis-dimethylpiperidine, 5.8 g (44 mmol) of cis-dimethylpiperidine hydrochloride, 0.34 g (5.5 mmol) of sodium cyanoborohydride and 1.5 g of 4 Å powdered, activated molecular sieves in 20 mL of methanol was stirred at room temperature for 2 days. The mixture was diluted with ethyl acetate and washed with saturated, aqueous Na 2  CO 3 , water and brine. Drying (MgSO 4 ) and removal of solvent gave an oil which was chromatographed on silica gel with 20:1 hexanes/ethyl acetate followed with 4:1 hexanes/ethyl acetate to elute 1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-6-oxabicyclo[3.1.0]hexan-2-yl-cis-3,5-dimethylpiperidine[1α,2β,5α]. 
     EXAMPLE 2 
     Synthesis of 1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-6-oxabicyclo[3.1.0] hexan-2-yl]-piperidine-[1α,2α,5α]hydrochloride 
     Trifluoroacetic anhydride (0.4 mL, 2.3 mmol) was added dropwise to a solution of 0.51 g (2.1 mmol) of 5-(4-t-butylphenyl)-1-methyl-6-oxabicyclo[3.1.0]-hexan-2-ol[1α,2.alpha.,5α] in 20 mL of pyridine at -5° C. The mixture was warmed to room temperature and stirred 1 hour before stripping off solvent. The residue was diluted with ethyl acetate and washed with 1N HCl, water and brine. Drying (MgSO 4 ) and removal of solvent gave 510 mg of 1-[5-[4-(1,1-dimethylethyl)-phenyl]-1-methyl-6-oxabicyclo[3.1.0]-hexan-2-yl]pyridinium[1α,2β,5α] chloride as an off white solid. 
     A solution of 0.4 g (1.2 mmol) of 1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-6-oxabicyclo[3.1.0]-hexan-2-yl]-pyridinium[1α,2β,5α] chloride, 0.4 g of 5% rhodium on alumina and 0.16 g (1.2 mmol) K 2  CO 3  in 50 mL of ethanol was hydrogenated at 1 atm. pressure for 17 hours at room temperature. The reaction mixture was filtered through a Celite® pad and rinsed through with ethyl acetate. Solvent was stripped and the residue was dissolved in ether. Some insoluble particulate matter was filtered off and solvent was stripped to afford an oil. The oil was dissolved in ether. An ethereal solution of 1N HCl was added and 0.21 g of 1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-6-oxabicyclo[3.1.0]hexan-2-yl]-piperidine[1α,2β,5α] hydrochloride precipitated as a white solid. 
     Examples of compounds of the invention are shown in Tables 1-2. Variables correspond to compounds of Formula I. Abbreviations are as follows: 
     t-Bu is tertiary butyl 
     i-Pr is isopropyl 
     Me is methyl 
     Et is phenyl 
     Ph is Phenyl 
     n-Bu is normal butyl 
     Bnz is benzyl 
     Me-O is methoxy 
     CN is cyano 
     Et-O is ethoxy 
     HO is hydroxy 
     TMS is trimethylsilyl. 
     
                                           TABLE 1__________________________________________________________________________ ##STR19## R.sup.1    R.sup.2           R.sup.3               ##STR20##        Q  Y__________________________________________________________________________4-TMSPh    Me  H   cis-3,5-di-Me-piperidine                                CH.sub.2                                  O4-TMSPh    Me  H   trans-3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   cis-3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   trans-3,5-di-Me-piperidine                                CH.sub.2                                  O4-CF.sub.3BuPh      Me  H   trans-3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   3-Me-piperidine   CH.sub.2                                  O4-TMSBuPh  Me  H   3-Me-piperidine   CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   pyrrolidine       CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   3,3-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   cis-3,5-di-Me-piperidine                                CH.sub.2                                  O4-  .sub.-t-BuPh      Me  H   piperidine        CH.sub.2                                  O4-TMSPh    Me  H   piperidine        CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   cis-di-Me-morpholine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  3-OMe              piperidine        CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   perhydro-iso-quinoline                                CH.sub.2                                  O4-TMSBuPh  Me  H   perhydro-iso-quinoline                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-(2-HOEt)-piperidine                                CH.sub.2                                  O4-TMSPh    Me  H   4-(2-HOEt)-piperidine                                CH.sub.2                                  O4-i-PrPh   Me  H   4-(2-HOEt)-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   di-Et-amine(trans R.sup.1 /N)                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   di-Et-amine(cis R.sup.1 /N)                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  3-OMe              pyrrolidine       CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   1,2,5,6-tetrahydro-pyridine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   3,5-di-Me-1,2,5,6-tetrahydropyridine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-Ph-piperidine   CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-Ph-piperidine   CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-HO-pyrazine     CH.sub.2                                  O4- .sub.- t-BuPh      Me  H   4-HO-pyrazine     CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-MeO-pyrazine    CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-MeO-pyrazine    CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-Me-pyrazine     CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4- .sub.-i-Pr-pyrazine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   3-CN-piperidine   CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   6-HO-4,4,8α-tri-Me-perhydro-                                CH.sub.2                                  O              iso-quinoline4- .sub.-t-BuPh      Me  H   6-HO-4,8α,-di-Me-perhydro-iso-                                CH.sub.2                                  O              quinoline4- .sub.-t-BuPh      Me  H   4-CN-piperidine   CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-(4-ClPh)-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-EtO-piperidine  CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4- -n-Bu-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-(2-HO-2-MePr)-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   2,6-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   4-CN-5-Me-1,2,5,6-tetrahydro-                                CH.sub.2                                  O              pyridine4- .sub.-t-BuPh      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  3-OMe              3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-i-PrPh      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.25-Me-2-heptyl      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.25-Me-hexyl Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.25-Me-2-heptenyl      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.2cyclohexyl Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      H   H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-i-PrPh      H   H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.25-Me-2-heptyl      H   H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.25-Me-hexyl H   H   3,5-di-Me-piperidine                                CH.sub.2                                  CH.sub.26-Me-2-heptenyl      H   H   3,5-di-Me-piperidine                                CH.sub.2                                  CH.sub.2cyclohexyl H   H   3,5-di-Me-piperidine                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      CN  H   3,5-di-Me-piperidine                                CH.sub.2                                  CH.sub.24- .sub.-i-PrPh      CN  H   3,5-di-Me-piperidine                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   3-Me-piperidine   CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   trans-perhydro-iso-quinoline                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   piperidine        CH.sub.2                                  CH.sub.24- .sub. -t-BuPh      Me  H   4-(2-HOEt)-piperidine                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   di-Et-amine       CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   1,2,5,6-tetrahydro-pyridine                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   3,5-di-Me-1,2,5,6-tetrahydro-                                CH.sub.2                                  CH.sub.2              pyridine4- .sub.-t-BuPh      Me  H   4-Ph-piperdine    CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   6-HO-4,8α-di-Me-perhydro-iso-                                CH.sub.2                                  CH.sub.2              quinoline4- .sub.-t-BuPh      Me  H   4-CN-piperidine   CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   3-CN-piperidine   CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   6-HO-4,4,8α-tri-Me-perhydro-                                CH.sub.2                                  CH.sub.2              iso-quinoline4- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                O CF.sub.24- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  CCl.sub.24- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                O C(CH.sub.3).sub.24- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  CHCN4- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                O CCN.sub.24- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  C(CH.sub.3)CN4- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                O CHCF.sub.34- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  CHCl4- .sub.-t-PrPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  CHOMe4- .sub.-i-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-Bu-cyclohexyl      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O6-Me-2-heptyl      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O5-Me-2-heptenyl      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O5-Me-hexyl Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-Bu-benzyl      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-i-PrPh      H   2-CH.sub.3              3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-i-PrPh      H   4-CH.sub.3              3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-i-PrPh      H   3-CH.sub.3              3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      H   3-OCH.sub.3              piperidine        CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      H   4-Cl              piperidine        CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      H   4-F piperidine        CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      H   4-CF.sub.3              piperidine        CH.sub.2                                  CH.sub.24- .sub.- t-BuPh      H   3-CF.sub.3              piperidine        CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      C.sub.2 H.sub.5          H   piperidine        CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      OC.sub.2 H.sub.5          H   piperidine        CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      CF.sub.3          H   3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      CH.sub.2 F          H   3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      CH.sub.2 Cl          H   3,5-di-Me-piperidine                                CH.sub.2                                  O4- .sub.-t-BuPh      CN  4-CH.sub.3              piperidine        CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      CN  3-CH.sub.3              piperidine        CH.sub.2                                  CH.sub.24-Cl-2-Me-benzyl      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-t-Bu-2-Me-benzyl      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.22,4-di-Cl-2-Me-benzyl      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.22,4-di-F-benzyl      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.24- .sub.-t-Bu-2-CN-benzyl      Me  H   3,4-di-Me-pyrrolidine                                CH.sub.2                                  CH.sub.24-[NCC(Me).sub.2 ]-phenyl      Me  H   pyrrolidine       CH.sub.2                                  CH.sub.24-Me-1-pentynyl      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O2-Cl-4- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O2-OMe-4- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O2-F-4- .sub.-i-Ph      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O4-CF.sub.3Ph      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O1-(4- .sub.-t-BuPh)-ethenyl      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O1-(4- .sub.-t-BuPh)-ethenyl      Me  H   piperidine        CH.sub.2                                  O1-(4- .sub.-t-BuPh)-ethenyl      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH.sub.21-(4- .sub.-t-BuPh)-ethenyl      Me  H   morpholine        CH.sub.2                                  CH.sub.24- -n-BuPh H   H   piperidine        O CH.sub.24- .sub.-t-Bu-cyclohexyl      H   H   piperidine        O CH.sub.2 -n-Bu     H   H   piperidine        O CF.sub.2cyclopentyl      H   H   piperidine        O CCl.sub.26-Me-hexyl H   H   piperidine        S CH.sub.24- .sub.-i-Pr-Ph      H   H   piperidine        S CH.sub.24- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  O              (N-oxide)4- .sub.-t-BuPh      Me  H   3,5-di-Me-piperidine                                CH.sub.2                                  CH.sub.2              (N-oxide)4- .sub.-t-BuPh      Me  H   piperidine(N-oxide)                                CH.sub.2                                  O4- .sub.-t-BuPh      Me  H   piperidine(N-oxide)                                CH.sub.2                                  CH.sub.24- .sub.-t-BuPh      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  O              (N-oxide)4- .sub.-t-BuPh      Me  H   3,5-di-Me-morpholine                                CH.sub.2                                  CH2              (N-oxide)4- .sub.-t-BuPh      Me  H   perhydro-iso-quinoline                                CH.sub.2                                  CH.sub.2              (N-oxide)__________________________________________________________________________ 
    
     
                                           TABLE 2__________________________________________________________________________ ##STR21## R.sup.1   R.sup.2         R.sup.3            Y                 ##STR22##  Q.sup.1                               Q.sup.2__________________________________________________________________________4- .sub.-i-Pr-Ph     Me H  O    morpholine CH.sub.2                              CH.sub.24- .sub.-t-BuPh     Me H  O    3,5-di-Me-morpholine                           CH.sub.2                              CH.sub.22,4-di-ClBnz     Me H  CH.sub.2                3,5-di-Me-morpholine                           CH.sub.2                              CH.sub.2 -n-pentyl     Me H  O    piperidine CH.sub.2                              CH.sub.21-CN-5-Me-1-hexyl     Me H  CH.sub.2                morpholine CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  H  O    3,5-di-Me-morpholine                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     Me H  O    3-piperidine                           CH.sub.2                              CH.sub.24- .sub.-i-PrPh     CN H  CH.sub.2                pyrrolidine                           CH.sub.2                              CH.sub.24-EtPh    CF.sub.3        H  CH.sub.2                2-Me-pyrrolidine                           CH.sub.2                              CH.sub.24- .sub.-i-PrPh      .sub.-i-Pr        H  O    2,5-di-Me-pyrrolidine                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  3-Me           O    3,5-di-Me-piperidine                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  5-F           CH.sub.2                3,5-di-Me-1,2,4,5-                           CH.sub.2                              CH.sub.2                tetrahydro-pyridine4- .sub.-t-BuPh     H  H  CCl.sub.2                4-MeO-piperazine                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  H  CF.sub.2                perhydro-iso-quinoline                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  H  C(CH.sub.3).sub.2                3-Me-morpholine                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  H  CHCN 3,5-di-Me-morpholine                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  H  CH( .sub.-i-Pr)                3,5-di-Me-morpholine                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     H  H  CH.sub.2                piperidine O  CH.sub.24- .sub.-t-BuPh     H  H  O    3,5-di-Me-piperidine                           CH.sub.2                              O4- .sub.-t-BuPh     H  H  CH.sub.2                3,5-di-Me-piperidine                           CH.sub.2                              S4- .sub.- t-BuPh     Me H  O    3,5-di-Me-piperidine                           CH.sub.2                              CH.sub.2                (N-oxide)4- .sub.-t-BuPh     Me H  CH.sub.2                3,5-di-Me-piperidine                           CH.sub.2                              CH2                (N-oxide)4- .sub.-t-BuPh     Me H  O    piperidine(N-oxide)                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     Me H  CH.sub.2                piperidine(N-oxide)                           CH.sub.2                              CH.sub.24- .sub.-t-BuPh     Me H  O    3,5-di-Me-morpholine                           CH.sub.2                              CH.sub.2                (N-oxide)4- .sub.-t-BuPh     Me H  CH.sub.2                3,5-di-Me-morpholine                           CH.sub.2                              CH.sub.2                (N-oxide)4- .sub.-t-BuPh     Me H  O    3,5-di-Me-piperidine                           O  CH.sub.2                (N-oxide)4- .sub.-t-BuPh     Me H  CH.sub.2                3,5-di-Me-piperidine                           O  CH.sub.2                (N-oxide)4- .sub.-t-BuPh     Me H  O    piperidine(N-oxide)                           O  CH.sub.24- .sub.-t-BuPh     Me H  CH.sub.2                piperidine(N-oxide)                           O  CH.sub.24- .sub.-t-BuPh     Me H  O    3,5-di-Me-piperidine                           CH.sub.2                              O                (N-oxide)4- .sub.-t-BuPh     Me H  CH.sub.2                3,5-di-Me-piperidine                           CH.sub.2                              O                (N-oxide)4- .sub.-t-BuPh     Me H  O    3-Me-piperidine                           CH.sub.2                              O                (N-oxide)__________________________________________________________________________ 
    
     Formulations 
     Useful formulations of the compounds of Formula I can be prepared in conventional ways. They include dusts, granules, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates and the like. Many of these may be applied directly. Sprayable formulations can be extended in suitable media and used at spray volumes of from a few liters to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation. The formulations, broadly, contain about 0.1% to 99% by weight of active ingredient(s) and at least one of (a) about 0.1% to 20% surfactants, and (b) about 1% to 99.9% solid or liquid inert diluent(s). More specifically, they will contain these ingredients in the following approximate proportions: 
     
         ______________________________________             Weight Percent*       Ingredient               Diluent(s)                         Surfactant(s)______________________________________Wettable Powders         20-90      0-74     1-10Oil Suspensions,          3-50     40-95     0-15Emulsions, Solutions,(including EmulsifiableConcentrates)Aqueous Suspension         10-50     40-84     1-20Dusts          1-25     70-99     0-5Granules and Pellets         0.1-95      5-99.9  0-15High Strength 90-99      0-10     0-2Compositions______________________________________ *Active ingredients plus at least one of a surfactant or a diluent equals 100 weight percent. 
    
     Lower or higher levels of active ingredient can, of course, be present depending on the intended use and the physical properties of the compound. Higher ratios of surfactant to active ingredient are sometimes desirable, and are achieved by incorporation into the formulation or by tank mixing. 
     Typical solid diluents are described in Watkins et al., &#34;Handbook of Insecticide Dust Diluents and Carriers&#34;, 2nd Ed., Dorland Books, Caldwell, N.J., but other solids, either mined or manufactured, may be used. The more absorptive diluents are preferred for wettable powders and the denser ones for dusts. Typical liquid diluents and solvents are described in Marsden, &#34;Solvents Guide&#34;, 2nd Ed., Interscience, New York, 1950. Solubility under 0.1% is preferred for suspension concentrates; solution concentrates are preferably stable against phase separation at 0° C. &#34;McCutcheon&#39;s Detergents and Emulsifiers Annual&#34;, MC Publishing Corp., Ridgewood, N.J., as well as Sisely and Wood, &#34;Encyclopedia of Surface Active Agents&#34;, Chemical Publishing Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foaming, caking, corrosion, microbiological growth, etc. 
     The methods of making such compositions are well known. Solutions are prepared by simply mixing the ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer or fluid energy mill. Suspensions are prepared by wet milling (see, for example, Littler, U.S. Pat. No. 3,060,084). Granules and pellets may be made by spraying the active material upon preformed granular carriers or by agglomeration techniques. See J. E. Browning, &#34;Agglomeration&#34;, Chemical Engineering, Dec. 4, 1967, pp. 147ff and &#34;Perry&#39;s Chemical Engineer&#39;s Handbook&#34;, 5th Ed., McGraw-Hill, New York, 1973, pp. 8-59ff. 
     For further information regarding the art of formulation, see for example: 
     H. M. Loux, U.S. Pat. No. 3,235,361, Feb. 15, 1966, Col. 6, line 16 through Col. 7, line 19 and Examples 10 through 41; 
     R. W. Luckenbaugh, U.S. Pat. No. 3,309,192, Mar. 14, 1967, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; 
     H. Gysin and E. Knusli, U.S. Pat. No. 2,891,855, Jun. 23, 1959, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; 
     G. C. Klingman, &#34;Weed Control as a Science&#34;, John Wiley &amp; Sons, Inc., New York, 1961, pp. 81-96; and 
     J. D. Fryer and S. A. Evans, &#34;Weed Control Handbook&#34;, 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pp. 101-103. 
     In the following examples, all parts are by weight unless otherwise indicated. One skilled in the art will recognize that Examples A, B, C, E, I, K, L and M are inappropriate wherein the active ingredient is an oil. 
     Example A 
     Wettable Powder 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    80%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]sodium alkylnaphthalenesulfonate                    2%sodium liginsulfonate    2%synthetic amorphous silica                    3%kaolinite                13%______________________________________ 
    
     The ingredients are blended, hammer-milled until all the solid are essentially under 50 microns, reblended, and packaged. 
     Example B 
     Wettable Powder 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    50%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]sodium alkylnaphthalenesulfonate                     2%low viscosity methyl cellulose                     2%diatomaceous earth       46%______________________________________ 
    
     The ingredients are blended, coarsely hammer-milled and then air-milled to produce particles essentially all below 10 microns in diameter. The product is reblended before packaging. 
     Example C 
     Granule 
     
         ______________________________________Wettable Powder of Example A                   5%attapulgite granules   95%(U.S.S. 20-40 mesh; 0.84-0.42 mm)______________________________________ 
    
     A slurry of wettable powder containing 25% solids is sprayed on the surface of attapulgite granules in a double-cone blender. The granules are dried and packaged. 
     Example D 
     Extruded Pellet 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    25%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]anhydrous sodium sulfate 10%crude calcium liginsulfonate                     5%sodium alkylnaphthalenesulfonate                     1%calcium/magnesium bentonite                    59%______________________________________ 
    
     The ingredients are blended, hammer-milled and then moistened with about 12% water. The mixture is extruded as cylinders about 3 mm diameter which are cut to produce pellets about 3 mm long. These may be used directly after drying, or the dried pellets may be crushed to pass a U.S.S. No. 20 sieve (0.84 mm openings). The granules held on a U.S.S. No. 40 sieve (0.42 mm openings) may be packaged for use and the fines recycled. 
     Example E 
     Oil Suspension 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    25%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]polyoxyethylene sorbitol hexaoleate                     5%highly aliphatic hydrocarbon oil                    70%______________________________________ 
    
     The ingredients are ground together in a sand mill until the solid particles have been reduced to under about 5 microns. The resulting thick suspensions may be applied directly, but preferably after being extended with oils or emulsified in water. 
     Example F 
     Wettable Powder 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    20%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]sodium alkylnaphthalenesulfonate                    4%sodium liginsulfonate    4%low viscosity methyl cellulose                    3%attapulgite              69%______________________________________ 
    
     The ingredients are thoroughly blended. After grinding in a hammer-mill to produce particles essentially all below 100 microns, the material is reblended and sifted through a U.S.S. No. 50 sieve (0.3 mm opening) and packaged. 
     Example G 
     Low Strength Granule 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    1%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]N,N-dimethylformamide    9%attapulgite granule      90%(U.S.S. 20-40 sieve)______________________________________ 
    
     The active ingredient is dissolved in the solvent and the solution is sprayed upon dedusted granules in a double cone blender. After spraying of the solution has been completed, the blender is allowed to run for a short period and then the granules are packaged. 
     Example H 
     Aqueous Suspension 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                      10%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]polyacrylic acid thickener 0.3%dodecylphenol polyethylene glycol                      0.5%etherdisodium phosphate         1%monosodium phosphate       0.5%polyvinyl alcohol          1.0%water                      86.7%______________________________________ 
    
     The ingredients are blended and ground together in a sand mill to produce particles essentially all under 5 microns in size. 
     Example I 
     Solution 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                     5%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α], HCl saltwater                    95%______________________________________ 
    
     The salt is added directly to the water with stirring to produce the solution, which may then be Packaged for use. 
     Example J 
     Low Strength Granule 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    0.1%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]attapulgite granules     99.9%(U.S.S. 20-40 mesh)______________________________________ 
    
     The active ingredient is dissolved in a solvent and the solution is sprayed upon dedusted granules in a double cone blender. After spraying of the solution has been completed, the material is warmed to evaporate the solvent. The material is allowed to cool and then packaged. 
     Example K 
     Granule 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    80%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]wetting agent             1%crude ligninsulfonate salt                    10%(containing 5-20% of the naturalsugars)attapulgite clay          9%______________________________________ 
    
     The ingredients are blended and milled to pass through a 100 mesh screen. This material is then added to a fluid bed granulator, the air flow is adjusted to gently fluidize the material, and a fine spray of water is sprayed onto the fluidized material. The fluidization and spraying are continued until granules of the desired size range are made. The spraying is stopped, but fluidization is continued, optionally with heat, until the water content is reduced to the desired level, generally less than 1%. The material is then discharged, screened to the desired size range, generally 14-100 mesh (1410-149 microns), and packaged for use. 
     Example L 
     High Strength Concentrate 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                     99%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]silica aerogel           0.5%synthetic amorphous silica                    0.5%______________________________________ 
    
     The ingredients are blended and ground in a hammer-mill to produce a material essentially all passing a U.S.S. No. 50 screen (0.3 mm opening). The concentrate may be formulated further if necessary. 
     Example M 
     Wettable Powder 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                     90%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]dioctyl sodium sulfosuccinate                    0.1%synthetic fine silica    9.9%______________________________________ 
    
     The ingredients are blended and ground in a hammer-mill to produce particles essentially all below 100 microns. The material is sifted through a U.S.S. No. 50 screen and then packaged. 
     Example N 
     Wettable Powder 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    40%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]sodium ligninsulfonate   20%montmorillonite clay     40%______________________________________ 
    
     The ingredients are thoroughly blended, coarsely hammer-milled and then air-milled to produce particles essentially all below 10 microns in size. The material is reblended and then packaged. 
     Example O 
     Oil Suspension 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    35%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]blend of polyalcohol carboxylic                     6%esters and oil-soluble petroleumsulfonatesxylene                   59%______________________________________ 
    
     The ingredients are combined and stirred together in a sand mill to produce a solution. The product can be extended with oils, or emulsified in water. 
     Example P 
     Dust 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    10%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]attapulgite              10%pyrophyllite             80%______________________________________ 
    
     The active ingredient is blended with attapulgite and then passed through a hammer-mill to produce particles substantially all below 200 microns. The ground concentrate is then blended with powdered pyrophyllite until homogeneous. 
     Example Q 
     Emulsifiable Concentrate 
     
         ______________________________________1-[5-[4-(1,1-dimethylethyl)phenyl]-1-methyl-                    20%6-oxabicyclo[3.1.0]hexan-2-yl]-cis-3,5-di-methylpiperidine, [1α,2β,5α]chlorobenzene            74%sorbitan monostearate and polyoxy-                     6%ethylene condensates thereof______________________________________ 
    
     The ingredients are combined and stirred to produce a solution which can be emulsified in water for application. 
     Utility 
     The compounds of this invention are useful as plant disease control agents. They provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete and Oomycete classes. They are effective in controlling a broad spectrum of plant diseases, particularly foliar pathogens of ornamental, vegetable, field, cereal, and fruit crops. These pathogens include, Erysiphe graminis, Uncinula necatur, Plasmopara viticola, Phytophthora infestans, Cerosporidium personatum, Cercospora arachidicola, Cercospora beticola, Botrytis cinerea, Podosphaera leucotricha, Venturia inaequalis, Puccinia recondita, Puccinia gramminis, Hemileia vastatrix, Puccinia striiformis, Puccinia arachidis, and other species closely related to these pathogens. They also control seed pathogens. 
     The compounds of this invention can be mixed with fungicides, bactericides, acaricides, nematicides, insecticides or other biologically active compounds in order to achieve desired results with a minimum of expenditure of time, effort and material. Suitable agents of this type are well-known to those skilled in the art. Some are listed below: 
     Fungicides 
     methyl 2-benzimidazolecarbamate (carbendazim) 
     tetramethylthiuram disulfide (thiuram) 
     n-dodecylguanidine acetate (dodine) 
     manganese ethylenebisdithiocarbamate (maneb) 
     1,4-dichloro-2,5-dimethoxybenzene (chloroneb) 
     methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate (benomyl) 
     2-cyano-N-ethylcarbamoyl-2-methoxyiminoacetamide (cymoxanil) 
     N-trichloromethylthiotetrahydrophthalamide (captan) 
     N-trichloromethylthiophthalimide (folpet) 
     dimethyl 4,4&#39;-(o-phenylene)bis(3-thioallophanate) (thiophanate-methyl) 
     2-(thiazol-4-yl)benzimidazole (thiabendazole) 
     aluminum tris(O-ethyl phosphonate)(phosethyl aluminum) 
     tetrachloroisophthalonitrile (chlorothalonil) 
     2,6-dichloro-4-nitroaniline (dichloran) 
     N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alanine methyl ester (metalaxyl) 
     cis-N-[1,1,2,2-tetrachloroethyl)thio]cyclohex-4-ene-1,2-dicarbioximide (captafol) 
     3-(3,5-dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidine carboxamide (iprodione) 
     3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione (vinclozolin) 
     kasugamycin 
     O-ethyl-S,S-diphenylphosphorodithioate (edifenphos) 
     4-(3-(4-(1,1-dimethyl-ethyl)phenyl)-2-methyl)propyl-2,6-dimethylmorpholine (fenpropimorph) 
     4-(3-4(1,1-dimethyl-ethyl)phenyl)-2-methyl)propylpiperidine (fenpropidine) 
     1-(4-chlorophenoxy)-3,3-dimethyl-1-1H-1,2,4-triazol-1-yl)butanone (triadimefon) 
     2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-hexanenitrile (myclobutanil) 
     α-[2-(4-chlorophenyl)ethyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol (tebuconazol) 
     3-chloro-4-[4-methyl-2-(1H-1,2,4-triazol)-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl-4-chlorophenyl ether (difenoconazole) 
     1-[2-(2,4-dichlorophenyl)pentyl]1H-1,2,4-triazole (penconazole) 
     (RS)-2,4&#39;-difluoro-a-(1H-1,2,4-triazole-1-ylmethyl)-benzhydryl alcohol (flutriafol) 
     1-[[bis(4-fluorophenyl)methylsilyl)methyl]-1H-1,2,4-triazole (flusilazol) 
     N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide (prochloraz) 
     (±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole (propiconazole) 
     α-(2-chlorophenyl)-α-(4-chlorophenyl)-5-pyrimidinemethanol (fenarimol) 
     1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazole-1-yl)butan-2-ol (triadimenol) 
     (2RS,3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol (diclobutrazol) 
     copper oxychloride 
     methyl N-(2,6-dimethylphenyl)-N-(2-furanylcarbonyl)-DL-alaninate (furalaxyl) 
     Bactericides 
     tribasic copper sulfate 
     streptomycin sulfate 
     oxytetracycline 
     Acaricides 
     senecioic acid, ester with 2-sec-butyl-4,6-dinitro-phenol (binapacryl) 
     6-methyl-1,3-dithiolo[2,3-B]quinonolin-2-one (oxythio-quinox) 
     2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol (dicofol) 
     bis(pentachloro-2,4-cyclopentadien-1-yl)(dienochlor) 
     tricyclohexyltin hydroxide (cyhexatin) 
     hexakis(2-methyl-2-phenylpropyl)distannoxane (fenbutatin oxide) 
     Nematicides 
     2-[diethoxyphosphinylimino]-1,3-diethietane (fosthietan) 
     S-methyl-1-(dimethylcarbamoyl)-N-(methylcarbamoyloxy)-thioformimidate (oxamyl) 
     S-methyl-1-carbamoyl-N-(methylcarbamoyloxy)thioformimidate 
     N-isopropylphosphoramidic acid, O-ethyl-O&#39;-[4-(methylthio)-m-tolyl]diester (fenamiphos) 
     Insecticides 
     3-hydroxy-N-methylcrotonamide(dimethylphosphate)ester (monocrotophos) 
     methylcarbamic acid, ester with 2,3-dihydro-2,2-dimethyl-7-benzofuranol (carbofuran) 
     O-[2,4,5-trichloro-a-(chloromethyl)benzyl]phosphoric acid, O&#39;,O&#39;-dimethyl ester (tetrachlorvinphos) 
     2-mercaptosuccinic acid, diethyl ester, S-ester with thionophosphoric acid, dimethyl ester (malathion) 
     phosphorothioic acid, O,O-dimethyl, O-p-nitrophenyl ester (methyl parathion) 
     methylcarbamic acid, ester with α-naphthol (carbaryl) 
     methyl N-[[(methylamino)carbonyl]oxy]ethanimidothioate (methomyl) 
     N&#39;-(4-chloro-o-tolyl)-N,N-dimethylformamidine (chlordimeform) 
     O,O-diethyl-O-(2-isopropyl-4-methyl-6-pyrimidyl)-phosphorothioate (diazinon) 
     octachlorocamphene (toxaphene) 
     O-ethyl O-p-nitrophenyl phenylphosphonothioate (EPN) 
     cyano(3-phenoxyphenyl)-methyl 4-chloro-α-(1-methylethyl)benzeneacetate (fenvalerate) 
     (3-phenoxyphenyl)methyl (+)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate (permethrin) 
     dimethyl N,N&#39;-[thiobis(N-methylimmo)carbonyloxy]]-bis[ethanimidothioate] (thiodicarb) 
     phosphorothiolothionic acid, O-ethyl-O-[4-(methylthio)phenyl]-S-n-propyl ester (sulprofos) 
     α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate (cypermethrin) 
     cyano(3-phenoxyphenyl)methyl 4-(difluoromethoxy)-α-(methylethyl)benzeneacetate (flucythrinate) 
     O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothioate (chlorpyrifos) 
     O,O-dimethyl-S-[(4-oxo-1,2,3-benzotriazin-3-(4H)-yl)-methyl]phosphorodithioate (azinphos-methyl) 
     5,6-dimethyl-2-dimethylamino-4-pyrimidinyl dimethyl carbamate (pirimicarb) 
     S-(N-formyl-N-methylcarbamoylmethyl)-O,O-dimethyl phosphorodithioate (formothion) 
     S-2-(ethylthioethyl)-O,O-dimethyl phosphiorothioate (demeton-S-methyl) 
     α-cyano-3-phenoxybenzyl cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane carboxylate (deltamethrin) 
     cyano(3-phenoxyphenyl)methyl ester of N-(2-chloro-4-trifluoromethylphenyl)alanine (fluvalinate) 
     Application 
     Disease control is ordinarily accomplished by applying an effective amount of the compound either pre-infection or post-infection to the portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing. The compound may also be applied to the seed, to protect the seed and seedling. 
     Rates of application for these compounds can be influenced by many factors of the environment and should be determined under actual use conditions. Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 5000 g/ha of active ingredient. Plants growing in soil treated at a concentration from 0.1 to about 20 kg/ha can be protected from disease. Seed and seedlings can normally be protected when seed is treated at a rate of from 0.1 to 10 g per kilogram of seed. 
     Test A 
     The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on apple seedlings. The following day the seedlings were inoculated with a spore suspension of Venturia inaequalis (the causal agent of apple scab) and incubated in a saturated atmosphere at 20° C. for 24 h, and then moved to a growth chamber at 22° C. for 11 days, after which disease ratings were made. 
     Test B 
     The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on peanut seedlings. The following day the seedlings were inoculated with a spore suspension of Cercosporidium personatum (the causal agent of peanut late leafspot) and incubated in a saturated atmosphere at 22° C. for 24 h, a high humidity atmosphere at 22° C. to 30° C. for 5 days, and then moved to a growth chamber at 29° C. for 6 days, after which disease ratings were made. 
     Test C 
     The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore dust of Erysiphe graminis f. sp. tritici, (the causal agent of wheat powdery mildew) and incubated in a growth chamber at 20° C. for 7 days, after which disease ratings were made. 
     Test D 
     The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore suspension of Puccinia recondita (the causal agent of wheat leaf rust) and incubated in a saturated atmosphere at 20° C. for 24 h, and then moved to a growth chamber at 20° C. for 6 days, after which disease ratings were made. 
     Test E 
     The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on tomato seedlings. The following day the seedlings were inoculated with a spore suspension of Phytophthor infestans (the causal agent of potato and tomato late blight) and incubated in a saturated atmosphere at 20° C. for 24 h, and then moved to a growth chamber at 20° C. for 5 days, after which disease ratings were made. 
     Test F 
     The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on grape seedlings. The following day the seedlings were inoculated with a spore suspension of Plasmopara viticola (the causal agent of grape downy mildew) and incubated in a saturated atmosphere at 20° C. for 24 h, moved to a growth chamber at 20° C. for 6 days, and then incubated in a saturated atmosphere at 20° C. for 24 h, after which disease ratings were made. 
     Test G 
     The test compounds were dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem 014 (polyhydric alcohol esters). This suspension was sprayed to the point of run-off on cucumber seedlings. The following day the seedlings were inoculated with a spore suspension of Botrytis cinerea (the causal agent of gray mold on many crops) and incubated in a saturated atmosphere at 20° C. for 48 h, and moved to a growth chamber at 20° C. for 5 days, after which disease ratings were made. 
     Results for Test A to G are given in Table A. In the table, a rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control (relative to the carrier sprayed controls). NT indicates that no test was performed. 
     
                                           INDEX TABLE A__________________________________________________________________________ ##STR23## CMPD NO.   R.sup.1         R.sup.2            R.sup.3              ##STR24##   Q  Y                               mp (°C.).sup.a__________________________________________________________________________1      4- .sub.-t-BuPh        Me H cis-3,5-di-Me-piperidine                         CH.sub.2                            O 118-1192      4- .sub.-t-BuPh        Me H 3-Me-piperidine                         CH.sub.2                            O 154-157                              (HCl salt)3      4- .sub.-t-BuPh        Me H piperidine  CH.sub.2                            O 124-1284      4- .sub.-t-BuPh        Me H cis-di-Me-morpholine                         CH.sub.2                            O 158-1615      4- .sub.-t-BuPh        Me H perhydro-iso-quinoline                         CH.sub.2                            O oil δ                              [1.2(s)]6      4- .sub.-t-BuPh        Me H 4-(2-HOEt)-piperidine                         CH.sub.2                            O 96-997      4- .sub.-t-BuPh        Me H di-Et-amine CH.sub.2                            O 144-146                              (HCl salt)8      4- .sub.-t-BuPh        Me H pyrrolidine CH.sub.2                            O 127-1289      4- .sub.-t-BuPh        Me H 4-Ph-piperidine                         CH.sub.2                            O 128-13210     4- .sub.-t-BuPh        Me H 3,3-di-Me-piperidine                         CH.sub.2                            O oil                              [0.45(s),                              1.0(s),                              1.2(s)]11     5-Me-hexyl        Me H cis-3,5-di-Me-piperidine                         CH.sub.2                            O oil                              [3.0(t)]12     5-Me-hexyl        Me H cis-3,5-di-Me-morpholine                         CH.sub.2                            O oil                              [3.0(t)]__________________________________________________________________________ .sup.a NMR data, given for oil, is in ppm downfield from tetramethylsiliane. Coupling are designated by (s)singlet, (d)doublet, (t)triplet, (q)quartet. 
    
     
                                           TABLE A__________________________________________________________________________Cmpd TEST TEST TEST TEST TEST TEST TESTNo.  A    B    C    D    E    F    G__________________________________________________________________________1    69   97   98   100  65   100  992    39   77   100  NT   26   NT    03    59   51   97   100   0   NT    04    98   66   98    83   0   NT   955    17   27    0   NT   25   NT   986    36   89   91   100  86   NT   837    88   56   94    18  26   NT    08    88   56   94    22  47   NT    09    NT   NT   NT   NT   NT   NT   NT10   NT   NT   NT   NT   NT   NT   NT11   NT   NT   NT   NT   NT   NT   NT12   NT   NT   NT   NT   NT   NT   NT__________________________________________________________________________